About the journal
MedChemComm is a journal published by Royal Society of Chemistry in United Kingdom. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Royal Society of Chemistry
- ISSN
- 2040-2503 · 2040-2511
- Country
- United Kingdom
- Access
- Not open access / not declared
- Official website
- http://www.rsc.org/Publishing/Journals/md/index.asp
Index listings
- PUBMED · 2010-08-01
- Indexing
- PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2024
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
2529
Last recorded publication year
2024
h-index
89
i10-index
1438
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 0%
Identity & continuity3
- Alternate titles
- Medicinal chemistry communications
- Source type
- journal
- NLM unique ID (PubMed)
- 101531525
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Synthesis and biological activity
- Synthesis and biological activity
- Click Chemistry and Applications
- Click Chemistry and Applications
- Computational Drug Discovery Methods
- Computational Drug Discovery Methods
- Synthesis and Biological Evaluation
- Synthesis and Biological Evaluation
Show all subjects (50)
- Chemical Synthesis and Analysis
- Chemical Synthesis and Analysis
- Cancer therapeutics and mechanisms
- Cancer therapeutics and mechanisms
- Receptor Mechanisms and Signaling
- Receptor Mechanisms and Signaling
- Bioactive Compounds and Antitumor Agents
- Bioactive Compounds and Antitumor Agents
- Microbial Natural Products and Biosynthesis
- Microbial Natural Products and Biosynthesis
- Carbohydrate Chemistry and Synthesis
- Carbohydrate Chemistry and Synthesis
- Peptidase Inhibition and Analysis
- Peptidase Inhibition and Analysis
- Biochemical and Molecular Research
- Biochemical and Molecular Research
- Metal complexes synthesis and properties
- Metal complexes synthesis and properties
- Legal and Regulatory Analysis
- Legal and Regulatory Analysis
- Military Technology and Strategies
- Military Technology and Strategies
- Linguistic, Cultural, and Literary Studies
- Linguistic, Cultural, and Literary Studies
- Antibiotic Resistance in Bacteria
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Characterization of Heterocyclic Compounds
- Antibiotic Resistance in Bacteria
- HIV/AIDS drug development and treatment
- HIV/AIDS drug development and treatment
- Diverse Scientific and Economic Studies
- Quinazolinone synthesis and applications
- Diverse Scientific and Economic Studies
- Quinazolinone synthesis and applications
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Cholinesterase and Neurodegenerative Diseases
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- Monoclonal and Polyclonal Antibodies Research
- Cholinesterase and Neurodegenerative Diseases
- Monoclonal and Polyclonal Antibodies Research
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ